Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

Franceschi, SSFranceschiLise, MMLiseClifford, G MG MCliffordRickenbach, MMRickenbachLevi, FFLeviMaspoli, MMMaspoliBouchardy, CCBouchardyDehler, SSDehlerJundt, GGJundtEss, SSEssBordoni, AABordoniKonzelmann, IIKonzelmannFrick, HHFrickDal Maso, LLDal MasoElzi, LLElziFurrer, HansjakobHansjakobFurrer0000-0002-1375-3146Calmy, AACalmyCavassini, MMCavassiniLedergerber, BBLedergerberKeiser, OliviaOliviaKeiser0000-0001-8191-27892024-10-102024-10-102010https://boris-portal.unibe.ch/handle/20.500.12422/71903The advent of highly active antiretroviral therapy (HAART) in 1996 led to a decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), but not of other cancers, among people with HIV or AIDS (PWHA). It also led to marked increases in their life expectancy.enChanging patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Studyarticle10.7892/boris.11622058827400028056130001810.1038/sj.bjc.6605756